| Name | Title | Contact Details |
|---|
Watercrest Senior Living Group specializes in the development and operations of assisted living and memory care communities, market repositioning and advisory services. The principals have an impressive track record of leading the turnaround of underperforming assets and the stabilization of newly built communities. Partnering with a wide variety of stakeholders such as land owners, real estate developers, investors, financial institutions, and REITs, Watercrest Senior Living Group focuses on its core strengths, operations management of assisted living and memory care communities and the development of servant leaders. With state of the art information systems and key vendor partnerships, we are well positioned to efficiently assimilate both existing assisted living and memory care communities and the next generation of senior living product.
Cognecy Solutions, LLC is a Mckinney, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
AMRA is the first in the world to transform images from a 6-minute whole body MRI scan into precise, 3D-volumetric, geographical fat and muscle measurements. Our aim is to redefine obesity and metabolic risk through precision medicine - understanding the interplay between fat, muscle and the development of metabolic disease.
Cimex Medical Innovations, L.C. is a Covington, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Making an impact on rare and serious skin and connective tissue diseases Fibrocell Science is at the forefront of the exciting and promising field of personalized biologics. By extracting cells from skin to create localized therapies that are compatible with the unique biology of each patient, personalized biologics bring a transformational approach to drug development. It is Fibrocell’s scientific leadership and legacy in cultivating and harnessing autologous fibroblast cells that fuels its personalized biologics approach. Fibrocell’s proprietary technology uses a person’s own fibroblast cells – with or without genetic modification – to target localized treatment of rare and serious skin and connective tissue diseases.